Regenxbio presented three-year durability data fo
Browsing: All news
Category Added in a WPeMatico Campaign
Immorta Bio Inc.
Variant Bio has expanded its multi-year research
As longevity moves toward increasingly personali
Pathways Bioscience announced that a randomized,
Coya Therapeutics hits its 100th ALS trial enrol
Inside the $230 billion our new Longevity Biotec
Telomir’s oncology compound helped fish with a
The Oxford biotech will present new mouse data o
Enveda raised $311 million to push its AI-discov